This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ tomoxetine hydrochloride,(prescription)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. ADHD Treatment: Atomoxetine is a selective norepinephrine reuptake inhibitor (SNRI) that works by increasing the levels of norepinephrine in the brain. It is approved for the treatment of ADHD as it helps improve attention span, concentration, impulse control, and other symptoms associated with ADHD. Atomoxetine is particularly beneficial for individuals who cannot tolerate stimulant medications or those with comorbid conditions such as anxiety disorders or substance abuse.

  2. Symptom Management: Atomoxetine helps reduce the core symptoms of ADHD, including inattention, hyperactivity, and impulsivity. It is effective in both children and adults and is often used as a long-term treatment to manage ADHD symptoms over time.

  3. Executive Functioning: Atomoxetine may also improve executive functioning skills such as organization, planning, and time management, which are commonly impaired in individuals with ADHD. By enhancing these cognitive abilities, atomoxetine can help individuals with ADHD better navigate daily tasks and responsibilities.

  4. Comorbid Conditions: Atomoxetine may be beneficial for individuals with ADHD who also have comorbid conditions such as anxiety disorders, depression, or oppositional defiant disorder (ODD). It can help alleviate symptoms of these conditions and improve overall functioning.

  5. Non-Stimulant Option: Atomoxetine is a non-stimulant medication, which means it does not have the same potential for abuse or dependence as stimulant medications commonly used to treat ADHD, such as methylphenidate or amphetamines. This makes it a preferred option for individuals with a history of substance abuse or those who do not respond well to stimulant therapy.

  6. Side Effects: Common side effects of atomoxetine may include nausea, vomiting, dry mouth, constipation, decreased appetite, insomnia, dizziness, fatigue, and mood swings. In some cases, it may also increase heart rate and blood pressure, so regular monitoring of cardiovascular parameters is recommended during treatment.

  7. Liver Function Monitoring: Atomoxetine has been associated with rare cases of liver injury, including elevated liver enzymes and hepatitis. Therefore, healthcare providers may monitor liver function periodically, especially during the initial months of treatment.

  8. Black Box Warning: Atomoxetine carries a black box warning regarding the increased risk of suicidal ideation in children, adolescents, and young adults with ADHD. Close monitoring for signs of worsening depression or suicidal thoughts is crucial, especially during the early stages of treatment or dosage adjustments.

;

Check for interactions on Supp.AI   |   📚 PubMed Citations

⚗️ Compensation for antibiotic usage

Data Contradictions — Limits of Certainity

Impacted of tomoxetine hydrochloride,(prescription) On Probiotics

Rank Probiotic Impact
species Akkermansia muciniphila Reduces
species Escherichia coli Reduces

Bacteria Impacted by tomoxetine hydrochloride,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

🧙?

📓 Direct Citations 👪👶 Indirect Citations Taxonomy Rank Effect
0 1 Akkermansiaceae family Decreases
0 1 Escherichia genus Decreases
0 1 Shigella genus Decreases
0 1 Agathobacter genus Decreases
0 1 Bacteroides genus Decreases
0 1 Phocaeicola genus Decreases
0 1 Mediterraneibacter genus Decreases
0 1 Lacrimispora genus Decreases
1 0 Akkermansia genus Decreases
0 1 Escherichia coli O1:K1:H7 no rank Decreases
0 1 Escherichia coli O139:H1 no rank Decreases
0 1 Escherichia coli O141:H4 no rank Decreases
0 1 Escherichia coli O145:H34 no rank Decreases
0 1 Escherichia coli O15:H12 no rank Decreases
0 1 Escherichia coli O155:H21 no rank Decreases
0 1 Escherichia coli O158:H23 no rank Decreases
0 1 Escherichia coli O16:H48 no rank Decreases
0 1 Escherichia coli O170:H18 no rank Decreases
0 1 Escherichia coli O18ac:H14 no rank Decreases
0 1 Escherichia coli O19:H7 no rank Decreases
0 1 Escherichia coli O2:K1:H4 no rank Decreases
0 1 Escherichia coli O2:K1:H5 no rank Decreases
0 1 Escherichia coli O2:K1:H7 no rank Decreases
0 1 Escherichia coli O20:H12 no rank Decreases
0 1 Escherichia coli O25:H16 no rank Decreases
0 1 Escherichia coli O55:H7 no rank Decreases
0 1 Escherichia coli O68:H12 no rank Decreases
0 1 Escherichia coli O7:H15 no rank Decreases
0 1 Escherichia coli O78:H51 no rank Decreases
0 1 Escherichia coli O80:H26 no rank Decreases
0 1 Escherichia coli O84:H7 no rank Decreases
0 1 Escherichia coli O85:H1 no rank Decreases
0 1 environmental samples no rank Decreases
0 1 unclassified Akkermansia no rank Decreases
0 1 Escherichia coli O103 serogroup Decreases
0 1 Escherichia coli O111 serogroup Decreases
0 1 Escherichia coli O119 serogroup Decreases
0 1 Escherichia coli O121 serogroup Decreases
0 1 Escherichia coli O145 serogroup Decreases
0 1 Escherichia coli O155 serogroup Decreases
0 1 Escherichia coli O157 serogroup Decreases
0 1 Escherichia coli O177 serogroup Decreases
0 1 Escherichia coli O26 serogroup Decreases
0 1 Escherichia coli O3 serogroup Decreases
0 1 Escherichia coli O43 serogroup Decreases
0 1 Escherichia coli O5 serogroup Decreases
0 1 Escherichia coli O78 serogroup Decreases
0 1 Escherichia coli O86 serogroup Decreases
0 1 Escherichia coli O91 serogroup Decreases
0 1 Escherichia coli H20 serotype Decreases
0 1 Escherichia coli O1:H42 serotype Decreases
0 1 Escherichia coli O1:HNT serotype Decreases
0 1 Escherichia coli O10:H32 serotype Decreases
0 1 Escherichia coli O10:K5(L):H4 serotype Decreases
0 1 Escherichia coli O100:H21 serotype Decreases
0 1 Escherichia coli O103:H11 serotype Decreases
0 1 Escherichia coli O103:H2 serotype Decreases
0 1 Escherichia coli O103:H25 serotype Decreases
0 1 Escherichia coli O104:H21 serotype Decreases
0 1 Escherichia coli O104:H4 serotype Decreases
0 1 Escherichia coli O111:H- serotype Decreases
0 1 Escherichia coli O111:H11 serotype Decreases
0 1 Escherichia coli O111:H8 serotype Decreases
0 1 Escherichia coli O111:NM serotype Decreases
0 1 Escherichia coli O112ab:H8 serotype Decreases
0 1 Escherichia coli O112ac:H19 serotype Decreases
0 1 Escherichia coli O113:H21 serotype Decreases
0 1 Escherichia coli O114:H49 serotype Decreases
0 1 Escherichia coli O118:H16 serotype Decreases
0 1 Escherichia coli O121:H19 serotype Decreases
0 1 Escherichia coli O121:H7 serotype Decreases
0 1 Escherichia coli O123:H11 serotype Decreases
0 1 Escherichia coli O125ac:K+:H10 serotype Decreases
0 1 Escherichia coli O126:H45 serotype Decreases
0 1 Escherichia coli O127:H27 serotype Decreases
0 1 Escherichia coli O127:H6 serotype Decreases
0 1 Escherichia coli O128:H2 serotype Decreases
0 1 Escherichia coli O128ac:H12 serotype Decreases
0 1 Escherichia coli O139:H28 serotype Decreases
0 1 Escherichia coli O145:H25 serotype Decreases
0 1 Escherichia coli O145:H28 serotype Decreases
0 1 Escherichia coli O145:NM serotype Decreases
0 1 Escherichia coli O146:H21 serotype Decreases
0 1 Escherichia coli O15:H18 serotype Decreases
0 1 Escherichia coli O150:H6 serotype Decreases
0 1 Escherichia coli O152:H23 serotype Decreases
0 1 Escherichia coli O153:H2 serotype Decreases
0 1 Escherichia coli O156:H25 serotype Decreases
0 1 Escherichia coli O157:H- serotype Decreases
0 1 Escherichia coli O157:H43 serotype Decreases
0 1 Escherichia coli O157:H7 serotype Decreases
0 1 Escherichia coli O157:NM serotype Decreases
0 1 Escherichia coli O16:H6 serotype Decreases
0 1 Escherichia coli O165:H25 serotype Decreases
0 1 Escherichia coli O167:H26 serotype Decreases
0 1 Escherichia coli O174:H2 serotype Decreases
0 1 Escherichia coli O174:H21 serotype Decreases
0 1 Escherichia coli O174:H8 serotype Decreases
0 1 Escherichia coli O176:H45 serotype Decreases
0 1 Escherichia coli O177:NM serotype Decreases
0 1 Escherichia coli O2:H6 serotype Decreases
0 1 Escherichia coli O2:K2:H1 serotype Decreases
0 1 Escherichia coli O25:H1 serotype Decreases
0 1 Escherichia coli O25:NM serotype Decreases
0 1 Escherichia coli O26:H1 serotype Decreases
0 1 Escherichia coli O26:H11 serotype Decreases
0 1 Escherichia coli O28ac:NM serotype Decreases
0 1 Escherichia coli O29:H4 serotype Decreases
0 1 Escherichia coli O32:H37 serotype Decreases
0 1 Escherichia coli O39:NM serotype Decreases
0 1 Escherichia coli O44:H18 serotype Decreases
0 1 Escherichia coli O45:H2 serotype Decreases
0 1 Escherichia coli O6:H16 serotype Decreases
0 1 Escherichia coli O6:H16:CFA/II serotype Decreases
0 1 Escherichia coli O6:K2:H1 serotype Decreases
0 1 Escherichia coli O69:H11 serotype Decreases
0 1 Escherichia coli O7:H4 serotype Decreases
0 1 Escherichia coli O7:K1 serotype Decreases
0 1 Escherichia coli O78:H12 serotype Decreases
0 1 Escherichia coli O78:H4 serotype Decreases
0 1 Escherichia coli O79:H7 serotype Decreases
0 1 Escherichia coli O8:H8 serotype Decreases
0 1 Escherichia coli O81:NM serotype Decreases
0 1 Escherichia coli O83:H1 serotype Decreases
0 1 Escherichia coli O86:H34 serotype Decreases
0 1 Escherichia coli O89m:H10 serotype Decreases
0 1 Escherichia coli O89m:H9 serotype Decreases
0 1 Escherichia coli O9:H10 serotype Decreases
0 1 Escherichia coli O91:H14 serotype Decreases
0 1 Escherichia coli O91:NM serotype Decreases
0 1 Escherichia coli O99:H6 serotype Decreases
0 1 Escherichia coli ONT:H33 serotype Decreases
1 0 Escherichia coli species Decreases
1 0 Bacteroides thetaiotaomicron species Decreases
1 0 Agathobacter rectalis species Decreases
0 1 Shigella dysenteriae species Decreases
0 1 Shigella flexneri species Decreases
0 1 Escherichia albertii species Decreases
0 1 Escherichia fergusonii species Decreases
0 1 Shigella boydii species Decreases
1 0 Phocaeicola vulgatus species Decreases
0 1 Shigella sonnei species Decreases
1 0 Mediterraneibacter gnavus species Decreases
0 1 Escherichia marmotae species Decreases
0 1 Escherichia sp. E4742 species Decreases
0 1 Bacteroides luhongzhouii species Decreases
0 1 Bacteroides faecium species Decreases
1 0 Lacrimispora saccharolytica species Decreases
0 1 Bacteroides xylanisolvens species Decreases
1 0 Bacteroides fragilis species Decreases
1 0 Akkermansia muciniphila species Decreases
0 1 Akkermansia glycaniphila species Decreases
0 1 Akkermansia massiliensis species Decreases
0 1 Candidatus Akkermansia intestinavium species Decreases

Impact of tomoxetine hydrochloride,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.6 0.6
ADHD 0.2 0.2
Allergic Rhinitis (Hay Fever) 0.7 0.7 0
Allergies 1.4 0.3 3.67
Allergy to milk products 0.9 0.5 0.8
Alzheimer's disease 0.9 1.5 -0.67
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.7 0.8 -0.14
Ankylosing spondylitis 1.5 0.3 4
Anorexia Nervosa 0.5 -0.5
Antiphospholipid syndrome (APS) 1.3 1.3
Asthma 0.9 0.3 2
Atherosclerosis 0.9 0 0
Atrial fibrillation 0.5 1.2 -1.4
Autism 1.3 2.3 -0.77
Autoimmune Disease 0.6 0.6
benign prostatic hyperplasia 0.6 0.2 2
Biofilm 0.9 0.9
Bipolar Disorder 0.7 0.7
Brain Trauma 0.2 -0.2
Breast Cancer 0.7 0.7
Carcinoma 0.5 0.2 1.5
Celiac Disease 1.2 0.2 5
Cerebral Palsy 0.2 0.2 0
Chronic Fatigue Syndrome 1 0.9 0.11
Chronic Kidney Disease 0.9 0.5 0.8
Chronic Lyme 0.2 -0.2
Chronic Obstructive Pulmonary Disease (COPD) 0.7 0.7
Chronic Urticaria (Hives) 1 0.1 9
Coagulation / Micro clot triggering bacteria 1.3 1.3
Cognitive Function 0.2 0.2
Colorectal Cancer 2.3 1.2 0.92
Constipation 1 1
Coronary artery disease 1.6 0.7 1.29
COVID-19 2.4 2 0.2
Crohn's Disease 2.3 0.8 1.87
Cushing's Syndrome (hypercortisolism) 0.4 -0.4
cystic fibrosis 1 0.2 4
d-lactic acidosis (one form of brain fog) 0.7 0.7
deep vein thrombosis 1.4 0.2 6
Depression 1.8 1.5 0.2
Eczema 0.7 0.1 6
Endometriosis 1.4 0.7 1
Epilepsy 1.5 0.3 4
erectile dysfunction 0.7 0.7
Fibromyalgia 0.2 -0.2
Functional constipation / chronic idiopathic constipation 1.7 0.2 7.5
gallstone disease (gsd) 1.3 0 0
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.3 0.3
Generalized anxiety disorder 1.6 0.2 7
Gout 0.3 0.3 0
Graves' disease 0.2 0.2 0
Gulf War Syndrome 0.8 -0.8
Halitosis 0.2 0.2
Hashimoto's thyroiditis 0.3 0.2 0.5
Heart Failure 1.6 0.5 2.2
Hidradenitis Suppurativa 0.2 0.2
High Histamine/low DAO 0.7 0.7
hypercholesterolemia (High Cholesterol) 0.7 0.1 6
hyperglycemia 1.3 0.3 3.33
Hyperlipidemia (High Blood Fats) 0 0
hypertension (High Blood Pressure 0.8 0.9 -0.13
Hypothyroidism 0 0
Hypoxia 0.2 0.2
IgA nephropathy (IgAN) 0.2 0.8 -3
Inflammatory Bowel Disease 2.4 1.7 0.41
Insomnia 0.2 0.5 -1.5
Intelligence 0.9 0.9
Intracranial aneurysms 0.2 0.2
Irritable Bowel Syndrome 2.2 0.5 3.4
ischemic stroke 0.9 1 -0.11
Liver Cirrhosis 1.5 1 0.5
Long COVID 1.8 1.1 0.64
Lung Cancer 0.6 0.1 5
Lymphoma 0.6 0.6
Mast Cell Issues / mastitis 0.6 0.6
ME/CFS with IBS 0.2 -0.2
ME/CFS without IBS 0.2 0.2 0
Menopause 0 0
Metabolic Syndrome 1.7 0.6 1.83
Mood Disorders 0.9 1.5 -0.67
multiple chemical sensitivity [MCS] 0 0
Multiple Sclerosis 0.9 0.7 0.29
Multiple system atrophy (MSA) 0.1 0.1
myasthenia gravis 0.6 0.6
neuropathic pain 0.2 -0.2
Neuropathy (all types) 0 0.3 0
neuropsychiatric disorders (PANDAS, PANS) 0.7 0.7
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 1.4 0.7 1
NonCeliac Gluten Sensitivity 0.2 0.2 0
Obesity 1.7 0.5 2.4
obsessive-compulsive disorder 1.5 0.6 1.5
Osteoarthritis 0.7 0.2 2.5
Osteoporosis 0.7 0.2 2.5
Parkinson's Disease 1.6 1.4 0.14
Polycystic ovary syndrome 1.2 0.2 5
Primary sclerosing cholangitis 0.2 0.2 0
Psoriasis 0.8 0.7 0.14
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 0.9 0.7 0.29
Schizophrenia 0.2 0.2 0
scoliosis 0.7 0.7
Sjögren syndrome 0.6 0.4 0.5
Sleep Apnea 0.2 0.2 0
Slow gastric motility / Gastroparesis 0.9 0.9
Small Intestinal Bacterial Overgrowth (SIBO) 0.9 0.9
Stress / posttraumatic stress disorder 1.1 0.2 4.5
Systemic Lupus Erythematosus 1 0.1 9
Tic Disorder 0.2 0.2
Tourette syndrome 0 0.2 0
Type 1 Diabetes 1.1 0.4 1.75
Type 2 Diabetes 2.3 1.9 0.21
Ulcerative colitis 1.7 1.2 0.42
Unhealthy Ageing 0.7 0.5 0.4
Vitiligo 0.2 0 0

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]